UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease – a SONIC post hoc analysis

Alimentary pharmacology & therapeutics, 2015-04, Vol.41 (8), p.734-746

2015

Volltextzugriff (PDF)

Anti-TNF-α treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial

Human reproduction (Oxford), 2008-09, Vol.23 (9), p.2017-2023

2008

Volltextzugriff (PDF)

Treatment with anti-TNF monoclonal antibody (c5N) reduces the extent of induced endometriosis in the baboon

Human reproduction (Oxford), 2006-07, Vol.21 (7), p.1856-1862

2006

Volltextzugriff (PDF)

Editorial: post hoc analysis of SONIC trial – authors’ reply

Alimentary pharmacology & therapeutics, 2015-06, Vol.41 (11), p.1211-1211

2015

Volltextzugriff (PDF)

Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study

Journal of Crohn's and colitis, 2019-10, Vol.13 (11), p.1387-1393

2019

Volltextzugriff (PDF)

Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain

Fertility and sterility, 1991-04, Vol.55 (4), p.759-765

1991

Volltextzugriff (PDF)

Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium

Fertility and sterility, 1991-07, Vol.56 (1), p.45-51

1991

Volltextzugriff (PDF)

Infliximab induces potent anti‐inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn’s disease

Alimentary pharmacology & therapeutics, 2001-04, Vol.15 (4), p.463-473

2001

Volltextzugriff (PDF)

Pharmakokinetische Daten sprechen für die frühe Dosisoptimierung bei Colitis ulcerosa (CU) Patienten mit Nicht-Ansprechen auf eine Golimumab Induktionstherapie

Zeitschrift für Gastroenterologie, 2018, Vol.56 (8), p.e220-e221

2018

Volltextzugriff (PDF)

Diagnosis of deep endometriosis by clinical examination during menstruation and plasma CA-125 concentration

Fertility and sterility, 1996-02, Vol.65 (2), p.280-287

1996

Volltextzugriff (PDF)

Deeply infiltrating pelvic endometriosis: histology and clinical significance

Fertility and sterility, 1990-06, Vol.53 (6), p.978-983

1990

Volltextzugriff (PDF)

The effect of endometriosis, cycle stage, lymphocyte suppression and pregnancy on CA-125 levels in peritoneal fluid and serum in baboons

Human reproduction (Oxford), 2005-11, Vol.20 (11), p.3033-3038

2005

Volltextzugriff (PDF)

Golimumab verbessert die vom Patienten berichtete Beeinträchtigung der Arbeitsproduktivität und Aktivität bei Patienten mit Colitis ulcerosa: 1 Jahresdaten einer nicht-interventionellen Studie in Deutschland

Zeitschrift für Gastroenterologie, 2018, Vol.56 (8), p.e213-e213

2018

Volltextzugriff (PDF)

Anti-TNF-a treatment for deep endometriosis-associated pain : a randomized placebo-controlled trial

Human reproduction (Oxford), 2008-09, Vol.23 (9), p.2017-2023

2008

Volltextzugriff (PDF)

Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review

BMJ open, 2019-05, Vol.9 (5), p.e027456-e027456

2019

Volltextzugriff (PDF)

Between learning and playing? Exploring learners’ perceptions of corrective feedback in an immersive game for English pragmatics

ReCALL (Cambridge, England), 2012-09, Vol.24 (3), p.257-278

2012

Volltextzugriff (PDF)

Patient Reported Outcomes (PROs) können zur Überprüfung des anhaltenden klinischen Ansprechens auf Golimumab (GLM) bei Patienten mit mäßiger bis schwerer aktiver Colitis Ulcerosa herangezogen werden: Ergebnisse der PURSUIT Maintenance Studie

Zeitschrift für Gastroenterologie, 2016, Vol.54 (8)

2016

Volltextzugriff (PDF)

P671 Calprotectin does not add accuracy to PRO2 for prediction of continuous clinical response in moderate-to-severe ulcerative colitis patients treated with golimumab

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S450-S450

2018

Volltextzugriff (PDF)

P698 Early dose optimisation in non-responders to golimumab induction treatment for ulcerative colitis is supported by pharmacokinetic data

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S464-S465

2018

Volltextzugriff (PDF)

P239 Real-life clinical and quality of life outcomes collected remotely from patients with moderate to severe active ulcerative colitis during induction treatment with golimumab in GO OBSERVE

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S216-S217

2019

Volltextzugriff (PDF)

CA125 and endometriosis

Human reproduction update, 1995-03, Vol.1 (2), p.173-187

1995

Volltextzugriff (PDF)

CA-125 and placental protein 14 concentrations in plasma and peritoneal fluid of women with deeply infiltrating pelvic endometriosis

Fertility and sterility, 1992-03, Vol.57 (3), p.523-530

1992

Volltextzugriff (PDF)

P453 Golimumab in real-world practice in patients with ulcerative colitis: 2-year interim results from a non-interventional trial in Germany

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S337-S338

2019

Volltextzugriff (PDF)

Prevalence and laparoscopic appearance of spontaneous endometriosis in the baboon (Papio anubis, Papio cynocephalus)

Biology of reproduction, 1991-09, Vol.45 (3), p.411-416

1991

Volltextzugriff (PDF)

P558 Golimumab improves patient-reported work productivity and activity impairment in patients with ulcerative colitis: Interim results from a non-interventional trial in Germany

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S388-S388

2018

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease – a SONIC post hoc analysis

Anti-TNF-α treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial

Treatment with anti-TNF monoclonal antibody (c5N) reduces the extent of induced endometriosis in the baboon

Editorial: post hoc analysis of SONIC trial – authors’ reply

Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study

Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain

Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium

Infliximab induces potent anti‐inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn’s disease

Pharmakokinetische Daten sprechen für die frühe Dosisoptimierung bei Colitis ulcerosa (CU) Patienten mit Nicht-Ansprechen auf eine Golimumab Induktionstherapie

Diagnosis of deep endometriosis by clinical examination during menstruation and plasma CA-125 concentration

Deeply infiltrating pelvic endometriosis: histology and clinical significance

The effect of endometriosis, cycle stage, lymphocyte suppression and pregnancy on CA-125 levels in peritoneal fluid and serum in baboons

Golimumab verbessert die vom Patienten berichtete Beeinträchtigung der Arbeitsproduktivität und Aktivität bei Patienten mit Colitis ulcerosa: 1 Jahresdaten einer nicht-interventionellen Studie in Deutschland

Anti-TNF-a treatment for deep endometriosis-associated pain : a randomized placebo-controlled trial

Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review

Between learning and playing? Exploring learners’ perceptions of corrective feedback in an immersive game for English pragmatics

Patient Reported Outcomes (PROs) können zur Überprüfung des anhaltenden klinischen Ansprechens auf Golimumab (GLM) bei Patienten mit mäßiger bis schwerer aktiver Colitis Ulcerosa herangezogen werden: Ergebnisse der PURSUIT Maintenance Studie

P671 Calprotectin does not add accuracy to PRO2 for prediction of continuous clinical response in moderate-to-severe ulcerative colitis patients treated with golimumab

P698 Early dose optimisation in non-responders to golimumab induction treatment for ulcerative colitis is supported by pharmacokinetic data

P239 Real-life clinical and quality of life outcomes collected remotely from patients with moderate to severe active ulcerative colitis during induction treatment with golimumab in GO OBSERVE

CA125 and endometriosis

CA-125 and placental protein 14 concentrations in plasma and peritoneal fluid of women with deeply infiltrating pelvic endometriosis

P453 Golimumab in real-world practice in patients with ulcerative colitis: 2-year interim results from a non-interventional trial in Germany

Prevalence and laparoscopic appearance of spontaneous endometriosis in the baboon (Papio anubis, Papio cynocephalus)

P558 Golimumab improves patient-reported work productivity and activity impairment in patients with ulcerative colitis: Interim results from a non-interventional trial in Germany

Suchergebnisse filtern